0001161697-24-000023.txt : 20240103 0001161697-24-000023.hdr.sgml : 20240103 20240103171847 ACCESSION NUMBER: 0001161697-24-000023 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240101 FILED AS OF DATE: 20240103 DATE AS OF CHANGE: 20240103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kalb Michael Wayne CENTRAL INDEX KEY: 0001678248 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33057 FILM NUMBER: 24508174 MAIL ADDRESS: STREET 1: 24 LUCILLE LANE CITY: DIX HILLS STATE: NY ZIP: 11746 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001369568 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 BUSINESS PHONE: (305) 529-2522 MAIL ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 FORMER COMPANY: FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC. DATE OF NAME CHANGE: 20110215 FORMER COMPANY: FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc. DATE OF NAME CHANGE: 20060719 3 1 form_3.xml FORM 3 FOR 01-01-2024 X0206 3 2024-01-01 0 0001369568 CATALYST PHARMACEUTICALS, INC. CPRX 0001678248 Kalb Michael Wayne 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 0 1 0 0 Executive Vice President & CFO Common Stock, par value $0.001 per share 0 D Options to purchase common stock 16.81 2031-01-01 Common Stock 257214 D Restricted Stock Units Common Stock 35693 D Derivative Securities vest in five annual tranches beginning on January 1, 2025. Shares of common stock will be delivered to the Reporting Person upon vesting. Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting. /s/ Michael W. Kalb 2024-01-03